Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Katharina Krause-Relle"'
Autor:
Oleg Tsuprykov, Lyubov Chaykovska, Axel Kretschmer, Johannes-Peter Stasch, Thiemo Pfab, Katharina Krause-Relle, Christoph Reichetzeder, Philipp Kalk, Jerzy Adamski, Berthold Hocher
Publikováno v:
Cellular Physiology and Biochemistry, Vol 37, Iss 4, Pp 1474-1490 (2015)
Background/Aims: To investigate the renal phenotype under conditions of an activated renal ET-1 system in the status of nitric oxide deficiency, we compared kidney function and morphology in wild-type, ET-1 transgenic (ET+/+), endothelial nitric oxid
Externí odkaz:
https://doaj.org/article/5b1c585ceffc469f957ae2e94a7da213
Autor:
Thomas Bernd Dschietzig, Katharina Krause-Relle, Maud Hennequin, Karoline von Websky, Jan Rahnenführer, Jana Ruppert, Hans Jürgen Grön, Franz Paul Armbruster, Ross A. D. Bathgate, Joerg R. Aschenbach, Wolf-Georg Forssmann, Berthold Hocher
Publikováno v:
Kidney & Blood Pressure Research, Vol 40, Iss 1, Pp 77-88 (2015)
Background/Aims: In diabetic nephropathy (DN), the current angiotensin-II-blocking pharmacotherapy is frequently failing. For diabetic cardiomyopathy (DC), there is no specific remedy available. Relaxin-2 (Rlx) - an anti-fibrotic, anti-inflammatory,
Externí odkaz:
https://doaj.org/article/7ef09891ceef4b01963b9c4d39fdd4b7
Autor:
Ina M Ott, Markus L Alter, Karoline von Websky, Axel Kretschmer, Oleg Tsuprykov, Yuliya Sharkovska, Katharina Krause-Relle, Jens Raila, Andrea Henze, Johannes-Peter Stasch, Berthold Hocher
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42623 (2012)
The prevalence of diabetes mellitus and its complications, such as diabetic nephropathy (DN), is rising worldwide and prevention and treatment are therefore becoming increasingly important. Therapy of DN is particularly important for patients who do
Externí odkaz:
https://doaj.org/article/a6202658b37c4c4399ca255f1e4e9112
Autor:
Ina Ott, Katharina Krause-Relle, Axel Kretschmer, Karoline von Websky, Berthold Hocher, Yuliya Sharkovska, Jens Raila, Johannes-Peter Stasch, Andrea Henze, Markus Alter, Oleg Tsuprykov
Publikováno v:
BMC Pharmacology
Background Riociguat is the first of a new class of drugs, the soluble guanylate cyclase (sGC) stimulators. Riociguat has a dual mode of action: it sensitizes sGC to the body’s own NO and can also increase sGC activity in the absence of NO. The NO-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11cb35a636155bc3df3e9e0e4e5b8c88
Autor:
Philipp Kalk, Oleg Tsuprykov, Jerzy Adamski, Berthold Hocher, Johannes-Peter Stasch, Thiemo Pfab, Lyubov Chaykovska, Christoph Reichetzeder, Katharina Krause-Relle, Axel Kretschmer
Publikováno v:
Cellular Physiology and Biochemistry, Vol 37, Iss 4, Pp 1474-1490 (2015)
Cell. Physiol. Biochem. 37, 1474-1490 (2015)
Cell. Physiol. Biochem. 37, 1474-1490 (2015)
Background/Aims: To investigate the renal phenotype under conditions of an activated renal ET-1 system in the status of nitric oxide deficiency, we compared kidney function and morphology in wild-type, ET-1 transgenic (ET+/+), endothelial nitric oxid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438b2ae86c6b95fb583b7b7251bd10ae
http://www.karger.com/Article/FullText/438516
http://www.karger.com/Article/FullText/438516
Autor:
Ina M. Ott, Oleg Tsuprykov, Katharina Krause-Relle, Thomas Klein, Markus Alter, Berthold Hocher, Yuliya Sharkovska, Jens Raila, Karoline von Websky, Andrea Henze
Publikováno v:
Kidney and Blood Pressure Research. 36:119-130
Background: The need for an improved treatment for diabetic nephropathy is greatest in patients who do not adequately respond to angiotensin II receptor blockers (ARBs). This study investigated the effect of the novel dipeptidyl peptidase-4 inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74a5a60fcee0c38784e9b891256cfcfb
https://doi.org/10.1159/000341487
https://doi.org/10.1159/000341487
Autor:
Jan Rahnenführer, Franz Paul Armbruster, Thomas Dschietzig, Joerg R. Aschenbach, Jana Ruppert, Wolf-Georg Forssmann, Katharina Krause-Relle, Maud Hennequin, Hans Jürgen Grön, Ross A. D. Bathgate, Karoline von Websky, Berthold Hocher
Publikováno v:
Kidney & Blood Pressure Research, Vol 40, Iss 1, Pp 77-88 (2015)
Background/Aims: In diabetic nephropathy (DN), the current angiotensin-II-blocking pharmacotherapy is frequently failing. For diabetic cardiomyopathy (DC), there is no specific remedy available. Relaxin-2 (Rlx) - an anti-fibrotic, anti-inflammatory,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c4bc06e406c33a52738d23827ddb59
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/39369
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/39369
Autor:
Karoline von Websky, Jens Raila, Johannes-Peter Stasch, Axel Kretschmer, Katharina Krause-Relle, Andrea Henze, Markus Alter, Berthold Hocher, Yuliya Sharkovska, Ina M. Ott, Oleg Tsuprykov
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 8, p e42623 (2012)
PLoS ONE, Vol 7, Iss 8, p e42623 (2012)
The prevalence of diabetes mellitus and its complications, such as diabetic nephropathy (DN), is rising worldwide and prevention and treatment are therefore becoming increasingly important. Therapy of DN is particularly important for patients who do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a56aed9f5dc9e8a9b8bfdc693e1766ce
http://europepmc.org/articles/PMC3416804
http://europepmc.org/articles/PMC3416804